We performed loss-of-function study in retinoblastoma cell lines, and found knocking down AFAP1-AS1 expression inhibited retinoblastoma cell proliferation, migration and invasion, and blocked cell cycle. The gene discussed is AFAP1; the disease is retinoblastoma.